We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+10.89%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14.8B
AUM Growth
+$1.41B
Cap. Flow
-$396M
Cap. Flow %
-2.67%
Top 10 Hldgs %
34.28%
Holding
1,311
New
31
Increased
615
Reduced
268
Closed
37

Sector Composition

Rank Sector Weight
1 Real Estate 59.19%
2 Technology 7.88%
3 Communication Services 4.43%
4 Consumer Discretionary 3.51%
5 Financials 3.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNDA icon
1101
Vanda Pharmaceuticals
VNDA
$318M
$3K ﹤0.01%
120
YMAB
1102
DELISTED
Y-mAbs Therapeutics
YMAB
$3K ﹤0.01%
76
NGM
1103
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$3K ﹤0.01%
146
IMGN
1104
DELISTED
Immunogen Inc
IMGN
$3K ﹤0.01%
384
AMTI
1105
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$3K ﹤0.01%
66
CNST
1106
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$3K ﹤0.01%
89
LMNX
1107
DELISTED
Luminex Corp
LMNX
$3K ﹤0.01%
87
AFMD
1108
DELISTED
Affimed
AFMD
$2K ﹤0.01%
19
AKRO
1109
DELISTED
Akero Therapeutics
AKRO
$2K ﹤0.01%
65
AMPH icon
1110
Amphastar Pharmaceuticals
AMPH
$842M
$2K ﹤0.01%
89
ANAB icon
1111
AnaptysBio
ANAB
$1.63B
$2K ﹤0.01%
60
ANNX icon
1112
Annexon
ANNX
$877M
$2K ﹤0.01%
72
ARCT icon
1113
Arcturus Therapeutics
ARCT
$164M
$2K ﹤0.01%
46
ATRA icon
1114
Atara Biotherapeutics
ATRA
$71M
$2K ﹤0.01%
6
CHRS icon
1115
Coherus Oncology
CHRS
$227M
$2K ﹤0.01%
135
COLL icon
1116
Collegium Pharmaceutical
COLL
$1.16B
$2K ﹤0.01%
76
DBC icon
1117
Invesco DB Commodity Index Tracking Fund
DBC
$1.67B
$2K ﹤0.01%
100
ENTA icon
1118
Enanta Pharmaceuticals
ENTA
$375M
$2K ﹤0.01%
38
IMVT icon
1119
Immunovant
IMVT
$8.28B
$2K ﹤0.01%
184
ITOS
1120
DELISTED
iTeos Therapeutics
ITOS
$2K ﹤0.01%
66
KROS icon
1121
Keros Therapeutics
KROS
$205M
$2K ﹤0.01%
44
LEGN icon
1122
Legend Biotech
LEGN
$3.72B
$2K ﹤0.01%
40
MRSN
1123
DELISTED
Mersana Therapeutics
MRSN
$2K ﹤0.01%
5
NKTX icon
1124
Nkarta
NKTX
$167M
$2K ﹤0.01%
61
NRIX icon
1125
Nurix Therapeutics
NRIX
$2.44B
$2K ﹤0.01%
73

Similar funds

Daiwa Securities Group's Q2 2021 Portfolio in Review

As of Q2 2021, Daiwa Securities Group held 1,311 positions worth $14.8B, up 10% from $13.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Daiwa Securities Group's Q2 2021 filing shows 31 new, 615 increased, 268 reduced and 37 closed positions. Its largest new stake was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M. The largest sale was Invitation Homes, an estimated $172M.

By sector, the portfolio is most concentrated in Real Estate at 59% of assets, down from 61% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q2 2021 buy was Algonquin Power & Utilities Corp Units: 325,000 shares worth $16.1M.
  • Daiwa Securities Group added most to AvalonBay Communities in Q2 2021, an estimated $175M increase.
  • Daiwa Securities Group's biggest Q2 2021 reduction was Invitation Homes, cutting an estimated $172M.
  • Daiwa Securities Group fully exited Global X Cloud Computing ETF in Q2 2021, selling an estimated $29.5M.
  • Daiwa Securities Group's ten largest holdings make up 34% of its $14.8B portfolio in Q2 2021.
  • Daiwa Securities Group opened 31 new positions and closed 37 in Q2 2021.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $14.8B.

Based on Daiwa Securities Group's 13F filing for Q2 2021, filed 6 Aug 2021.